bpc 157 human clinical trials safety bpc-157 evidence review regulatory status Gastric pentadecapeptide body protection compound bpc-157 human clinical trials evidence

(1) Treating anemia depending on the cause can be explained as follows: 1.Iron deficiency anemia Iron deficiency is the most common cause of anemia, and is generally treated by: (2)(12) Iron supplements in the form of pills or syrup once daily, usually for 3-6 months

In March 2025 it will be a year since the Nice Guideline on B12 Deficiency in over 16s was published

BPC-157 promotes robust granulation tissue formation, accelerated re-epithelialization, and improved tensile strength of healing wounds

"Prostate enlargement (benign prostatic hyperplasia)"

If choosing between them, AOD-9604 has the stronger evidence base and regulatory standing

It is not a drug, supplement, or medical device, and it must not be administered to humans or animals